Elyssa Rubin • UCI Profiles (original) (raw)

  1. Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement. J Natl Compr Canc Netw. 2024 Dec 27; 23(1). Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM. PMID: 39729709; PMCID: PMC11881167.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  2. Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of Neuroblastoma. Pediatr Blood Cancer. 2025 Jan; 72(1):e31425. Tan SY, Evans MG, Saab R, Gupta A, Reid J, Dao T, Rubin E, Crymes A, Semenova K, Shimada H, Livasy C, Nael A. PMID: 39502074.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. Children's Oncology Group's 2023 blueprint for research: Bone tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30583. Reed DR, Grohar P, Rubin E, Binitie O, Krailo M, Davis J, DuBois SG, Janeway KA. PMID: 37501549; PMCID: PMC10499366.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  4. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390306. Wood GE, Graves LA, Rubin EM, Reed DR, Riedel RF, Strauss SJ. PMID: 37220319.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  5. Data standards in pediatric oncology: Past, present, and future. Pediatr Blood Cancer. 2023 02; 70(2):e30128. Wyatt KD, Noyd DH, Wood NM, Phillips CA, Miller TP, Rubin EM, Winestone LE, Waanders AJ, Perentesis JP, Aplenc R. PMID: 36495256.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  6. Birth Characteristics and Risk of Early-Onset Synovial Sarcoma. Cancer Epidemiol Biomarkers Prev. 2020 06; 29(6):1162-1167. Wiemels JL, Wiemels JL, Wang R, Feng Q, Clark CJ, Amatruda JF, Rubin E, Yee AC, Morimoto LM, Metayer C, Ma X. PMID: 32245786; PMCID: PMC7605594.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  7. Congenital neuroglial choristoma of the foot. Radiol Case Rep. 2019 Jun; 14(6):718-722. Glavis-Bloom J, Nahl D, Rubin EM, Nael A, Dao T. PMID: 30988863; PMCID: PMC6447744.
    View in: PubMed Mentions: 3
  8. Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia. Pediatr Transplant. 2013 May; 17(3):E104-7. Buchbinder D, Hsieh L, Puthenveetil G, Soni A, Stites J, Huynh V, Kirov I, Neudorf S, Rubin E, Sender L, Torno L, Margolis D, Childs R, Moore T, Nugent D. PMID: 23464883; PMCID: PMC4174564.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  9. The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Rev Anticancer Ther. 2011 Aug; 11(8):1223-32. McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH. PMID: 21916576.
    View in: PubMed Mentions: 47 Fields:
    Translation:HumansAnimalsCells
  10. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther. 2010 Mar; 9(3):731-41. Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH. PMID: 20197388; PMCID: PMC2837364.
    View in: PubMed Mentions: 76 Fields:
    Translation:HumansAnimalsCells
  11. Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model. Clin Orthop Relat Res. 2008 Sep; 466(9):2039-45. Guo Y, Rubin EM, Xie J, Zi X, Hoang BH. PMID: 18566875; PMCID: PMC2493003.
    View in: PubMed Mentions: 35 Fields:
    Translation:AnimalsCells
  12. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling. Cancer Res. 2008 May 01; 68(9):3350-60. Guo Y, Xie J, Rubin E, Tang YX, Lin F, Zi X, Hoang BH. PMID: 18451162; PMCID: PMC2824245.
    View in: PubMed Mentions: 44 Fields:
    Translation:HumansAnimalsCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs